JGJames M. Gregory

James M. Gregory

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


James M. Gregory has a total of 142 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dynamic Acromiohumeral Bone Surface Proximity and Scapuloclavicular Kinematics in Nonoperatively Managed Acromioclavicular Joint Injuries

    by Jason Konrath, Sydney Wheaton, Alonso Figueroa, James Gregory, Payam Zandiyeh

    Background: Abnormal scapular biomechanics after acromioclavicular joint (ACJ) disruption may increase susceptibility to secondary pathologies such as subacromial impingement and rotator cuff degeneration. Traditionally, nonoperative management is suggested for low-grade disruptions (Rockwood types ≤3). However, the effects of ACJ disruption on dynamic scapular mechanics and acromiohumeral bone surface proximity in patients managed nonoperatively remain unexplored. Purpose: To quantify in vivo scapuloclavicular and glenohumeral kinematics, as well as acromiohumeral bone surface proximity, during dynamic humeral elevation in patients with nonoperatively managed ACJ injuries, using subject-specific bone models and biplanar video-radiography (BVR). Study Design: Cross-sectional study; Level of evidence, 3. Methods: Ten participants (9 male, 1 female; mean age, 42 ± 10 years) with previous ACJ disruption classified as Rockwood type III-V were enrolled 1 to 3 years after injury. Participants underwent 3-dimensional (3D) computed tomography and BVR during abduction, scaption, and flexion. Patient-specific bone models were registered to the BVR data to quantify scapular, clavicular, and humeral kinematics. Regions of interest (ROIs) were defined on the scapular and humeral surface models to represent the supraspinatus footprint and inferior acromial surface. The minimum 3D Euclidean distance between ROIs and their anatomical locations was calculated for each movement. Results: The injured limb demonstrated greater scapular upward rotation and internal rotation relative to the clavicle during scaption and flexion. During forward flexion, the minimum bone surface proximity between the supraspinatus footprint and the inferior acromion also occurred at a more anterior location. Additionally, the injured limb reached minimum proximity earlier at lower elevation angles compared with the contralateral limb. Conclusion: Patients with nonoperatively managed ACJ disruption exhibit an anterior shift in acromiohumeral proximity during flexion, accompanied by increased scapular internal rotation. These findings suggest that subtle alterations in dynamic scapuloclavicular coordination may alter which regions of the coracoacromial arch are encountered by the supraspinatus tendon, potentially influencing localized mechanical loading and impingement mechanisms. Improved understanding of dynamic scapuloclavicular coupling may help refine rehabilitation strategies and inform treatment stratification.

  • Open Access

    Augmentation of Arthroscopic Rotator Cuff Repair Using Enthesis Interpositional Allograft and Minced Autologous Subacromial Bursa

    by Matthew D. Smith, Shyon K. Ahmadi, James M. Gregory

    Multiple strategies for rotator cuff augmentation have been developed to promote tendon healing and decrease retear rates. Previously published techniques and clinical studies have primarily emphasized biologic adjuncts intended to alter the local healing environment at the repair site or structural reinforcement with grafts. Although autologous subacromial bursal tissue has a potential benefit through local delivery of mesenchymal stem cells, it is difficult to maintain at the repair site. In vitro studies of scaffold augmentation with a demineralized interpositional graft are promising and would allow for the addition of biologic adjuncts directly at the repair site. Each strategy for augmentation offers distinct advantages and disadvantages, and the complimentary mechanisms of graft and biologic augmentation allow them to be combined. This technical note describes an augmentation technique for arthroscopic rotator cuff repair that incorporates an interpositional biphasic allograft in conjunction with autologous subacromial bursal tissue. The described technique provides a scaffold for healing at the enthesis while simultaneously delivering autologous tissue to promote tendon‐to‐bone healing. A combined strategy may represent a practical approach to optimizing repair integrity in patients at increased risk of failure after rotator cuff repair.

  • Open Access

    The Reliability of the Forgotten Joint Score for Shoulder Arthroplasty

    by Madilyn L. Feik, Ashley Z. Smith, Kevin K. Chen, Zachary A. Gehring, Natalie L. Myers, James M. Gregory

  • Open Access

    Safety and Effectiveness of Placental Connective Tissue Matrix Allograft Versus Corticosteroid Injection in Adhesive Capsulitis: A Double-Blinded Prospective Randomized Study

    by Olivia C. Nembhard, Janice M. Pogoda, James M. Helm, James M. Gregory, Jessica Waters, Ajai Sambasivan, Evan Meeks, Paul Shupe, Eric F. Berkman

    Background: Adhesive capsulitis causes significant pain and functional limitation, with limited effective treatment options. Current standard-of-care treatments, such as corticosteroid injections, may offer short-term symptom relief but are associated with limited long-term efficacy and potential side effects. Regenerative therapies using extracellular matrix–based products derived from placental tissue have shown promise in treating musculoskeletal injuries due to their anti-inflammatory and tissue-healing properties. Clinical data supporting their use in adhesive capsulitis remains limited. The objective of this study was to compare the safety and effectiveness of a flowable placental connective tissue matrix allograft (PCTMA) vs. corticosteroid injection for adhesive capsulitis. Hypothesis: We hypothesized that intra-articular injection of a placental connective tissue allograft would result in superior clinical outcomes compared with corticosteroid injection for adhesive capsulitis of the shoulder. Study Design: Randomized controlled clinical trial. Methods: This double-blinded prospective study randomized patients with adhesive capsulitis to receive either intra-articular PCTMA (1 cc) with lidocaine (study group, n = 25) or corticosteroid injection with triamcinolone 20 mg and lidocaine (control group, n = 27). Inclusion criteria included ages 18 to 75 years, clinical diagnosis of adhesive capsulitis, shoulder pain >6 weeks, and MRI confirmation without other shoulder pathology. The primary end point was change from baseline in Shoulder Pain and Disability Index (SPADI) score. Secondary end points included Visual Analog Scale (VAS), American Shoulder and Elbow Surgeons (ASES) score, and passive range of motion. Assessments occurred at 4, 12, and 24 weeks postinjection. Results: Both groups improved over time. At 24 weeks, mean SPADI improvement was similar between groups [PCTMA: −40.4 (SD 18.81) vs. corticosteroid: −37.7 (SD 30.12)] (p = 0.73), but post hoc responder analyses favored PCTMA: SPADI responders 88% vs. 63% (p = 0.04), VAS responders 80% vs. 56% (p = 0.06), and ASES responders 88% vs. 56% (p = 0.01). One serious adverse event unrelated to the study intervention was reported. Conclusion: Flowable intra-articular PCTMA demonstrated a favorable safety profile and comparable improvements in pain and disability to corticosteroid injection at 24 weeks. A post hoc responder analysis favored PCTMA, suggesting potential for more sustained clinical benefit warranting further investigation. Clinical Relevance: This study provides the first randomized controlled comparison of PCTMA vs. corticosteroid injection for adhesive capsulitis, offering preliminary evidence to guide treatment selection and informing the design of future, larger-scale trials investigating biologic therapies for this condition. Trial Registration: The authors confirm that the protocol was finalized before patient enrollment. Clinical trial registration (NCT05844930) was completed in April 2023. Level of Evidence: Therapeutic Level II .See Instructions for Authors for a complete description of levels of evidence.

  • Open Access

    Clinical and Demographic Factors Associated With Baseline PROMIS Categorization in Shoulder and Elbow Patients

    by Matthew W. Brewer, Madison R. Smith, Jordan S. Roylance, Sage A. Copling, Zachary A. Gehring, Thomas Guffey, Sean M. Kennedy, John E. Conway, James M. Gregory, Natalie L. Myers

    Background: Patient-Reported Outcomes Measurement Information System (PROMIS) computer adaptive tests (CATs) are commonly used in orthopaedics. While prior work has validated PROMIS domains in upper extremity populations, there is limited literature describing associations of clinical and demographic factors with baseline PROMIS score categorization in shoulder and elbow patients. Hypothesis: It was hypothesized that sex, operative status, body mass index (BMI), age, and injured body region would be associated with baseline PROMIS-Pain Interference (PI) and PROMIS-Physical Function (PF) categorization. Study Design: Cross-sectional study; Level of evidence, 3. Methods: A retrospective analysis was performed between March 2022 and March 2025. Patients ≥18 years of age with a primary complaint of shoulder or elbow pain were included. PROMIS-PI and PROMIS-PF CATs were completed at the initial visit. Multinomial logistic regression was used to examine associations of impairment severity (mild, moderate, or severe), with the within normal limits group as the reference category. Independent variables included injured body part, sex, operative status, BMI, and age. A secondary analysis limited to shoulder patients incorporated primary encounter diagnosis as an additional factor. Results: The primary analysis included a cohort of 1324 patients (977 shoulder, 347 elbow; mean age, 53 ± 16 years; 43.7% female). Injured body part was not associated with impairment severity. Among this cohort, women were more likely to demonstrate all levels of PI (OR, 1.38-2.50) and moderate to severe PF impairment (OR, 1.90-3.24). Operative status was associated with greater odds of moderate to severe PI (OR, 2.00-3.78) and PF impairment (OR, 2.40-2.85). BMI ≥30 was associated with greater odds of moderate to severe PI (OR, 1.52-2.45) and all levels of PF impairment (OR, 1.50-2.76). Older age was modestly associated with severe PI and mild to severe PF impairment. In the shoulder-only cohort, rotator cuff pathology and arthritis were associated with lower likelihoods of severe impairment, while adhesive capsulitis was associated with mild to moderate PI but lower odds of severe PF impairment. Conclusion: Female sex, operative status, higher BMI, and advanced age were associated with worse baseline PROMIS-PI and PF categorization, while shoulder-specific diagnoses demonstrated variable associations.

  • Open Access

    Surgical Timing After Acromioclavicular Joint Separation: Association With Clinical Outcomes

    by Mallory B. Lane, Jacob Siahaan, James M. Gregory

    Background: Treatment of acromioclavicular joint (ACJ) separations continually lacks consensus between providers, and while low-grade injuries generally respond well to conservative management, high-grade injury management is more complex. For patients requiring surgery, the effect of the timing of surgery with respect to the original injury on clinical outcomes remains unclear. Hypothesis: Clinical outcome measures would worsen as the time between ACJ dislocation injury and surgery increased. Study Design: Cohort study; Level of evidence, 3. Methods: A large nationwide insurance claims database was queried for patients who had an ACJ dislocation injury using International Classification of Diseases, Ninth and Tenth Revision (ICD-9 and ICD-10) codes. Surgical management via ACJ repair or ACJ reconstruction was identified using Current Procedural Terminology codes 23550 and 23552, respectively. The time between the date of initial ACJ dislocation diagnosis and the date of surgery was used to separate patients into 4 temporal subgroups with the following parameters: 0 to 4 weeks, 4 weeks to 3 months, 3 months to 1 year, and after 1 year. Clinical outcomes—including complication rate, infection rate, and fracture rate—were compared between temporal and procedural subgroups. Outcomes were compared using chi-square tests. Results: A total of 13,194 patient met the inclusion criteria and were included in the study, of whom 8639 received surgical management of their ACJ dislocation within 4 weeks of initial injury diagnosis, 2210 between 4 weeks and 3 months, 1264 between 3 months and 1 year, and 1081 more than 1 year after injury diagnosis. The rate of all measured adverse clinical outcomes increased over time as surgical management was delayed in the ACJ repair subgroup, and the rates of revisions and complications increased over time as surgical management was delayed in the ACJ reconstruction subgroup. Conclusion: The rate of all measured adverse clinical outcomes increased over time as surgical management was delayed in the ACJ repair subgroup, and the rate of revisions and complications increased over time as surgical management was delayed in the ACJ reconstruction subgroup. Further research is needed to define the role of injury severity and classification in these outcomes and identify which patients would benefit from early surgical intervention.

  • Open Access

    Preliminary In Vivo Evaluation of Coracoclavicular Ligament Mechanics During Shoulder Elevation After Acromioclavicular Joint Reconstruction

    by Jason Konrath, Sydney Wheaton, Alonso Figueroa, James Gregory, Payam Zandiyeh

    Background: Persistent instability and altered scapular mechanics after acromioclavicular joint (ACJ) reconstruction may stem from inadequate replication of native coracoclavicular (CC) ligament function. However, in vivo data on postoperative CC ligament behavior during dynamic shoulder motion remain lacking. Purpose: To assess in vivo functional distance and timing characteristics of the conoid and trapezoid ligaments during active shoulder elevation after ACJ reconstruction, using dynamic stereo x-ray (DSX) imaging and patient-specific 3-dimensional (3D) models. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Twelve participants (10 men and 2 women, mean age 39 ± 10 years, mean body mass 92 ± 17 kg) who had sustained an acute unilateral ACJ disruption (Rockwood classification of 3-5) and undergone anatomic ACJ reconstruction were recruited within 1 to 3 years after surgery. Participants underwent 3D computed tomography (CT) and DSX imaging to capture abduction, scaption, and flexion movements. Patient-specific bone models with digitized CC insertion points were then aligned within each frame of the biplanar radiograph images. From this, the peak functional distance, time at peak, and displacement were measured and compared with the uninjured limb. Results: Compared with uninjured limbs, the reconstructed limb demonstrated increased conoid and trapezoid peak distances of 23% and 17% between insertion points, respectively, across abduction, flexion, and scaption. Additionally, the conoid and trapezoid reached these peak distances at later stages of the movement cycle, and experienced increased displacement by 2.7 and 1.8 mm, respectively, in the reconstructed limb. Conclusion: This investigation established the methodological feasibility of using DSX combined with patient-specific CT models to quantify in vivo ligament behavior during functional shoulder motion. It further identified significant asymmetries in the functional distance between conoid and trapezoid ligament insertion points when comparing reconstructed and uninjured limbs across multiple shoulder elevation movements.

  • Effect of Subacromial Bursa Augmentation on Self-Reported and Magnetic Resonance Imaging Outcomes in Arthroscopic Rotator Cuff Repair: A Prospective, Blinded Randomized Clinical Trial

    by James M. Gregory, Ashley Z. Smith, Payam Zandiyeh

    Background: Rotator cuff repair (RCR) failure remains a persistent clinical challenge despite advances in surgical techniques. Although the subacromial bursa—historically excised during repair—is recognized for its regenerative potential due to its rich population of connective tissue progenitor cells, high-quality clinical evidence supporting its utility as an autologous biological adjunct remains lacking. Hypothesis: Subacromial bursa augmentation during arthroscopic RCR improves patient-reported outcomes and magnetic resonance imaging (MRI)–based tendon healing compared with standard repair. Study Design: Randomized controlled trial; Level of evidence, 2. Methods: A total of 67 patients undergoing primary arthroscopic repair for full- or near-full-thickness supraspinatus tears were randomized to receive either standard repair (control; n = 34) or repair with minced subacromial bursa reimplantation (cases; n = 33). All patients underwent identical surgical repair constructs. Patient-reported outcomes (American Shoulder and Elbow Surgeons [ASES], Simple Shoulder Test [SST], and PROMIS [Patient-Reported Outcomes Measurement Information System] Upper Extremity and Global scores) were collected at baseline and at multiple intervals up to 24 months. MRI was used to evaluate tendon integrity (Sugaya classification) and supraspinatus tendon thickness at a minimum of 6 months postoperatively. Generalized estimating equations and chi-square tests were used for longitudinal and categorical comparisons. Results: Patient-reported outcomes improved significantly over time in both the control and augmentation groups. While no statistically significant between-group differences were observed overall, the bursa augmentation group demonstrated a higher Global score at 6 months ( P = .047). Across other time points, outcomes, including PROMIS, ASES, SST, and Global ratings, did not show significant differences. MRI analysis at 6 months reflected a similar pattern, and no significant differences were detected. A smaller proportion of patients in the augmentation group exhibited high-grade Sugaya types (3-5: 28% vs 39% in the control group), and retear dimensions were generally smaller. Conclusion: In this randomized clinical trial, subacromial bursa augmentation did not improve tendon healing or clinical outcomes after arthroscopic RCR. These results clearly reject the initial hypothesis that bursal augmentation enhances the healing of repair. While the procedure appeared safe and feasible, the absence of measurable benefit indicates that its routine clinical use cannot be supported at this time. Registration: NCT04634084 (ClinicalTrials.gov identifier).